THAO TRAN: Open Payments
NPI 1346715661 · GARDEN GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 19 payments from 7 companies in 2025. Trend: 2023 $879 · 2024 $592 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $190 |
| Lilly USA, LLC | 4 | $105 |
| Insulet Corporation | 2 | $65 |
| Dexcom, Inc. | 2 | $54 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Mannkind Corporation | 1 | $16 |
Products named: Ozempic, MOUNJARO, Wegovy, Omnipod, Dexcom G6 Transmitter, ISTURISA, GVOKE HYPOPEN, AFREZZA.
Industry payments across CA — which companies pay providers there.
